Parallax Volatility Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,400
| Closed | -$5.4M | – | 1595 |
|
|
2025
Q4 | $5.4M | Buy |
15,400
+400
| +3% | +$135K | 0.01% | 647 |
|
|
2025
Q3 | $4.85M | Buy |
+15,000
| New | +$4.67M | 0.01% | 686 |
|
|
2025
Q2 | – | Sell |
-2,300
| Closed | -$1M | – | 1622 |
|
|
2025
Q1 | $1M | Buy |
+2,300
| New | +$923K | ﹤0.01% | 1052 |
|
|
2024
Q4 | – | Sell |
-1,300
| Closed | -$676K | – | 2100 |
|
|
2024
Q3 | $676K | Buy |
1,300
+300
| +30% | +$160K | ﹤0.01% | 1453 |
|
|
2024
Q2 | $542K | Sell |
1,000
-14,000
| -93% | -$7.4M | ﹤0.01% | 1420 |
|
|
2024
Q1 | $7.78M | Buy |
15,000
+7,400
| +97% | +$3.68M | 0.02% | 588 |
|
|
2023
Q4 | $3.58M | Hold |
7,600
| – | – | 0.01% | 951 |
|
|
2023
Q3 | $3.31M | Sell |
7,600
-700
| -8% | -$318K | 0.01% | 913 |
|
|
2023
Q2 | $3.69M | Sell |
8,300
-17,900
| -68% | -$8.26M | 0.01% | 907 |
|
|
2023
Q1 | $12M | Sell |
26,200
-43,000
| -62% | -$20.5M | 0.02% | 524 |
|
|
2022
Q4 | $35.5M | Sell |
69,200
-4,700
| -6% | -$2.39M | 0.06% | 360 |
|
|
2022
Q3 | $33.6M | Buy |
73,900
+50,700
| +219% | +$24.3M | 0.05% | 385 |
|
|
2022
Q2 | $11.2M | Buy |
23,200
+22,200
| +2,220% | +$11M | 0.01% | 685 |
|
|
2022
Q1 | $491K | Buy |
+1,000
| New | +$457K | ﹤0.01% | 1911 |
|
|
2020
Q4 | – | Sell |
-228,800
| Closed | -$61.5M | – | 2869 |
|
|
2020
Q3 | $61.5M | Buy |
228,800
+102,900
| +82% | +$27.7M | 0.05% | 349 |
|
|
2020
Q2 | $33.1M | Buy |
125,900
+49,800
| +65% | +$13.3M | 0.04% | 367 |
|
|
2020
Q1 | $17.3M | Buy |
76,100
+26,400
| +53% | +$7.19M | 0.02% | 440 |
|
|
2019
Q4 | $15M | Buy |
49,700
+47,000
| +1,741% | +$12.9M | 0.02% | 515 |
|
|
2019
Q3 | $648K | Sell |
2,700
-41,800
| -94% | -$11.5M | ﹤0.01% | 1537 |
|
|
2019
Q2 | $12.6M | Buy |
44,500
+32,000
| +256% | +$8.74M | 0.01% | 465 |
|
|
2019
Q1 | $3.59M | Sell |
12,500
-75,700
| -86% | -$21.9M | ﹤0.01% | 785 |
|
|
2018
Q4 | $23.2M | Buy |
88,200
+52,200
| +145% | +$14.4M | 0.03% | 314 |
|
|
2018
Q3 | $9.87M | Buy |
+36,000
| New | +$9.35M | 0.01% | 484 |
|
|
2016
Q2 | – | Sell |
-200
| Closed | -$28K | – | 2717 |
|
|
2016
Q1 | $28K | Sell |
200
-300
| -60% | -$40.1K | ﹤0.01% | 2245 |
|
|
2015
Q4 | $70K | Buy |
+500
| New | +$68.9K | ﹤0.01% | 2238 |
|
|
2015
Q3 | – | Sell |
-200
| Closed | -$33K | – | 3135 |
|
|
2015
Q2 | $33K | Sell |
200
-3,200
| -94% | -$511K | ﹤0.01% | 2712 |
|
|
2015
Q1 | $523K | Sell |
3,400
-45,300
| -93% | -$6.45M | ﹤0.01% | 1529 |
|
|
2014
Q4 | $6.12M | Sell |
48,700
-87,700
| -64% | -$10.8M | 0.02% | 621 |
|
|
2014
Q3 | $16.3M | Buy |
136,400
+126,700
| +1,306% | +$14.5M | 0.05% | 316 |
|
|
2014
Q2 | $1.04M | Sell |
9,700
-2,700
| -22% | -$278K | ﹤0.01% | 1018 |
|
|
2014
Q1 | $1.24M | Buy |
12,400
+800
| +7% | +$72.4K | 0.01% | 712 |
|
|
2013
Q4 | $1.07M | Sell |
11,600
-2,900
| -20% | -$258K | 0.01% | 825 |
|
|
2013
Q3 | $1.21M | Buy |
14,500
+9,600
| +196% | +$823K | 0.01% | 630 |
|
|
2013
Q2 | $402K | Buy |
+4,900
| New | +$367K | ﹤0.01% | 869 |
|
Other funds holding ELV
VCM
VPM
Parallax Volatility Advisers's ELV Position: Q1 2026 in Review
Parallax Volatility Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,576 shares — an estimated $552K sold.
Parallax Volatility Advisers first reported a position in ELV in Q2 2013 and held it in 29 quarters. The position peaked at $15.3M in Q3 2020. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Parallax Volatility Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Parallax Volatility Advisers sold 1,576 Elevance Health shares in Q1 2026, an estimated $552K.
- Parallax Volatility Advisers first reported a position in Elevance Health in Q2 2013 and held it in 29 quarters.
- Parallax Volatility Advisers's Elevance Health position peaked at $15.3M in Q3 2020.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.